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ABSTRACT The membrane interactions and position of a positively charged and highly aromatic peptide derived from
a secretory carrier membrane protein (SCAMP) are examined using magnetic resonance spectroscopy and several biochemical
methods. This peptide (SCAMP-E) is shown to bind to membranes containing phosphatidylinositol 4,5-bisphosphate, PI(4,5)P2,
and sequester PI(4,5)P2 within the plane of the membrane. Site-directed spin labeling of the SCAMP-E peptide indicates that
the position and structure of membrane bound SCAMP-E are not altered by the presence of PI(4,5)P2, and that the peptide
backbone is positioned within the lipid interface below the level of the lipid phosphates. A second approach using high-
resolution NMR was used to generate a model for SCAMP-E bound to bicelles. This approach combined oxygen enhancements
of nuclear relaxation with a computational method to dock the SCAMP-E peptide at the lipid interface. The model for SCAMP
generated by NMR is consistent with the results of site-directed spin labeling and places the peptide backbone in the bilayer
interfacial region and the aromatic side chains within the lipid hydrocarbon region. The charged side chains of SCAMP-E lie well
within the interface with two arginine residues lying deeper than a plane deﬁned by the position of the lipid phosphates. These
data suggest that SCAMP-E interacts with PI(4,5)P2 through an electrostatic mechanism that does not involve speciﬁc lipid-
peptide contacts. This interaction may be facilitated by the position of the positively charged side chains on SCAMP-E within
a low-dielectric region of the bilayer interface.
INTRODUCTION
Phosphatidylinositol is a membrane phospholipid that has
a number of different phosphorylated forms, each of which
plays a critical role in mediating cell-signaling events
(Cremona and De Camilli, 2001; Czech, 2000; DiNitto
et al., 2003; Hurley and Meyer, 2001; Martin, 2001;
Overduin et al., 2001; Simonsen et al., 2001; Toker, 1998).
Among these polyphosphoinositides, phosphatidylinositol 4,
5-bisphosphate (PI(4,5)P2) is the most abundant and the best
characterized. PI(4,5)P2 is the precursor for three other
signaling molecules, inositol trisphosphate (IP3), diacylgly-
cerol (DAG), and phosphatidylinositol 3,4,5-trisphosphate
(PI(3,4,5)P3), but PI(4,5)P2 also acts directly as a second
messenger regulating numerous events including enzyme
activation, ion channel function (Runnels et al., 2002; Wu
et al., 2002), membrane trafﬁcking (Cremona and De
Camilli, 2001; Martin, 2001; Simonsen et al., 2001), and
membrane-cytoskeletal interactions (Raucher et al., 2000;
Sechi and Wehland, 2000; Sheetz, 2001).
PI(4,5)P2 regulates many diverse functions in response to
intermittent cellular signals. To achieve this regulation it has
been proposed that a signiﬁcant fraction of the PI(4,5)P2
within the membrane is bound to proteins, which then release
PI(4,5)P2 locally in response to speciﬁc cellular signals
(Caroni, 2001; McLaughlin et al., 2002). There is good
evidence that proteins may bind and sequester PI(4,5)P2
through an electrostatic mechanism. In this case, highly
positively charged regions of proteins that are localized at the
membrane interface interact electrostatically with PI(4,5)P2
(which has a valence of from3 to4 at neutral pH) to alter
the lateral heterogeneity of PI(4,5)P2 (Gambhir et al., 2004;
McLaughlin et al., 2002; Rauch et al., 2002; Wang et al.,
2001, 2002, 2004).
The highly charged effector domain of the myristoylated
alanine-rich C-kinase substrate (MARCKS-ED) is an
example of a membrane-associated protein segment that
binds and sequesters PI(4,5)P2 within the plane of the
membrane through an electrostatic mechanism (Gambhir
et al., 2004; Wang et al., 2004). A peptide derived from the
MARCKS-ED binds to membranes containing PI(4,5)P2
with high afﬁnity (Wang et al., 2001), and inhibits the
activity of phospholipase C (PLC), an enzyme that hydro-
lyzes PI(4,5)P2 at the membrane interface (Wang et al.,
2002). EPR measurements using a spin-labeled derivative of
PI(4,5)P2 indicate that the MARCKS-ED binds ;3 mole-
cules of PI(4,5)P2, and site-directed spin labeling of the
MARCKS-ED peptide suggests that neither speciﬁc van der
Waals contacts nor hydrogen bonds are required for the
peptide-PI(4,5)P2 interaction (Rauch et al., 2002). There
appear to be two mechanisms to reverse the binding of
PI(4,5)P2 by MARCKS. In the ﬁrst, MARCKS is
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phosphorylated within its effector domain segment by
protein kinase C, thereby reducing its positive charge and
releasing PI(4,5)P2. In the second, the presence of high
intracellular Ca21 activates Ca21-calmodulin, which binds
the effector domain segment of MARCKS and removes it
from the membrane interface.
The MARCKS-ED (residues 151–175) is a highly charged
segment containing 13 positively charged residues and ﬁve
phenylalanines. A peptide corresponding to the MARKCKS-
ED is positioned at the membrane interface as an extended
structure, with its ﬁve phenylalanine residues buried 510 A˚
below the level of the lipid phosphates (Ellena et al., 2003;
Qin and Caﬁso, 1996; Zhang et al., 2003). The position of
this peptide at the membrane interface appears to be im-
portant in its ability to sequester PI(4,5)P2. When the ﬁve
phenylalanine residues of the MARCKS-ED peptide are
replaced by alanine residues, the peptide binds but no longer
penetrates the membrane interface (Victor et al., 1999); in
addition, the ability of this peptide to sequester PI(4,5)P2 is
diminished (Gambhir et al., 2004). Thus, aromatic residues
in the MARCKS-ED may function to position this peptide at
the membrane interface. At the time of this study, direct
information on the position of the positively charged
residues in the MARCKS-ED has not been obtained. A
number of other charged peptides also appear to bind and
sequester PI(4,5)P2, and the ability of these peptides to
sequester PI(4,5)P2 generally increases with the amount of
charge and the number of aromatic residues in the sequence
(Wang et al., 2002). However, there is little structural
information on the membrane interactions made by these
peptides.
In this work, we investigate the PI(4,5)P2 binding and
membrane position of a basic, aromatic 11-residue peptide
derived from a secretory carrier membrane protein (SCAMP).
SCAMPs are membrane proteins with four membrane-
spanning helical segments (Hubbard et al., 2000) that function
in membrane fusion during exocytosis (Fernandez-Chacon
et al., 1999; Guo et al., 2002; Liu et al., 2002). The SCAMP-
derived peptide examined here, CWYRPIYKAFR or
E-peptide, is derived from a short, highly conserved
cytoplasm-facing segment linking the second and third
transmembrane helices of SCAMP2 (Hubbard et al., 2000).
This peptide is a sequence-speciﬁc and late-acting inhibitor of
exocytosis in permeabilized mast cells and neuroendocrine
(PC12) cells (Guo et al., 2002; Liu et al., 2002). Using an
electron paramagnetic resonance (EPR)-based assay and
a measurement of PLC activity on monolayers, we provide
evidence that SCAMP-E peptide has the capacity to bind and
sequester PI(4,5)P2 within the plane of the bilayer. SDSL is
used to position the peptide in the membrane interface and
suggests that the interactions with PI(4,5)P2 are electrostatic
in origin. We also utilize high-resolution NMR to generate
a model for the position of the SCAMP-E peptide in the lipid
interface. In this model the aromatic side chains of the peptide
are located in the lipid hydrocarbon region and the charged
amino acid side chains lie at or deeper than the level of the
lipid phosphates. The deep position of the charged residues of
this peptide is consistent with an electrostatic mechanism for
the sequestration of PI(4,5)P2 by SCAMP-E.
MATERIAL AND METHODS
Materials
All phospholipids were obtained from Avanti Polar Lipids (Alabaster, AL).
A number of peptides based on the human SCAMP-E sequence were
synthesized and are listed in Table 1. The human SCAMP-E peptide and two
structural variants with residues switched were synthesized and puriﬁed by
the Biomolecular Research Facility at the University of Virginia, and the
identity of each peptide was conﬁrmed by mass spectrometry. These
peptides were blocked at the C-terminus, but had a free N-terminus, so that
the valence was 14 at neutral pH. The native SCAMP-E sequence was also
synthesized along with two analogs with cysteines at positions 6 and 9
(Ac-SWYRPCYKAFR-NH and Ac-SWYRPIYKCFR-NH) using a Gilson
automated peptide synthesizer (AMS 422; Gilson, Middletown, WI) as
described previously (Hubbard et al., 2000). Each of these peptides were
acetylated at the N-terminus and had a valence of13 (loss of the N-terminal
charge on this peptide did not signiﬁcantly alter the ability of this peptide to
interact with proxyl-PI(4,5)P2). These peptides were spin-labeled (Scheme 1)
with the sulfhydryl reactive methanethiosulfonate spin label (MTSL),
(1-oxy-3-methanesulfonylthiomethyl-2,2,5,6-tetramethyl-2,5-dihydro-1H
pyrroline), which was purchased from Toronto Research Chemicals
(Toronto, Ontario, Canada). A radiolabeled version of SCAMP-E was
produced by derivatizing the N-terminal cysteine of puriﬁed SCAMP-E
peptide with 3H-NEM as described previously (Arbuzova et al., 2000) and
repuriﬁed by high-performance liquid chromatography (HPLC). The
identity of all peptides was conﬁrmed by mass spectrometry, and each had
a purity in excess of 97% as determined by HPLC and in-line detection by
ultraviolet spectrometry of the peptide backbone at 210 nm. A spin-labeled
derivative of PI(4,5)P2, proxyl-PI(4,5)P2 (Scheme 1), was obtained from
Echelon Biosciences (Salt Lake City, UT) (Prestwich, 2004).
Lipid vesicle preparation
Lipid vesicles were formed from either palmitoyloleoylphosphatidylcholine
(PC) and mixtures of POPC with palmitoyloleoylphosphatidylserine (PS)
and/or PI(4,5)P2. Lipid vesicles were produced by mixing the appropriate
lipids from stock solutions in chloroform. The chloroform was removed by
vacuum desiccation, and the resulting lipid ﬁlm was hydrated in a buffer
containing 100 mM KCl, 10 mM 3-morpholinopropanesulfonic acid
(MOPS), pH 7.0. The lipid mixture was taken through ﬁve freeze-thaw
cycles, and unilamellar vesicles were produced by extrusion of the mixture
TABLE 1 SCAMP-E peptides synthesized
Peptide Sequence
Human SCAMP-E NH2-CWYRPIYKAFR-NH or
Ac-CWYRPIYKAFR-NH
E peptide with 6/11 switch NH2-CWYRPRYKAFI-NH
E peptide with 4/5 and 9/10/11
switch
NH2-CWYPRIYKRAF-NH
3H labeled SCAMP-E NH2-(Cys-NEM)WYRPIYKAFR-NH
C1R1 Ac-(R1)WYRPIYKAFR-NH
I6R1 Ac-SWYRP(R1)YKAFR-NH
A9R1 Ac-SWYRPIYK(R1)FR-NH
3222 Ellena et al.
Biophysical Journal 87(5) 3221–3233
through 1000-A˚ polycarbonate ﬁlters (Poretics, Livermore, CA) using
a LiposoFast extruder (Avestine, Ottawa, Ontario). In the experiments
described here, the spin-labeled proxyl-PI(4,5)P2 was incorporated into the
outer membrane leaﬂet by adding the vesicle solution to a dried ﬁlm of
proxyl-PI(4,5)P2. This procedure was shown previously to quantitatively
incorporate proxyl-PI(4,5)P2 into the outer leaﬂet of the vesicle bilayer
(Rauch et al., 2002). Either unlabeled or spin-labeled versions of the
SCAMP-E peptide were added directly to preformed lipid vesicle sus-
pensions from an aqueous stock solution of peptide.
Centrifugation binding measurements
Membrane binding was determined by the use of 3H-NEM SCAMP-E
peptide using a centrifugation assay described previously (Wang et al.,
2002) and was carried out by Jiyao Wang in the laboratory of Stuart
McLaughlin. The levels of peptide in the supernatant and pellet fraction
were determined by scintillation counting and used to calculate the fraction
of membrane-bound peptide, FB. The binding was then expressed as a
reciprocal molar binding constant K as given by:
FB ¼ K½L
11K½L; (1)
where [L] represents the accessible lipid concentration. We assume that
SCAMP-E does not cross the bilayer and take [L] to be half the total lipid
concentration. As described elsewhere (Buser and McLaughlin, 1998), it is
important that the peptide does not signiﬁcantly alter the total surface charge
under the conditions of the binding titration. Hence, care was taken to ensure
that the experiment was carried out under conditions where the accessible
lipid concentration greatly exceeded the bound peptide concentration.
PLC monolayer assay
The activity of either PLC-d1 or PLC-b was measured on lipid monolayers
as described previously (Wang et al., 2002) and was carried out by Jiyao
Wang in the laboratory of Stuart McLaughlin. Brieﬂy, the SCAMP-E
peptide was added to the subphase at the indicated concentrations, and the
levels of 3H-IP3, which resulted from the PLC hydrolysis of
3H-PI(4,5)P2 in
the monolayer, were measured in the subphase by scintillation counting.
EPR spectroscopy
EPR spectra for either proxyl-PI(4,5)P2 or spin-labeled SCAMP-E peptides,
were obtained at X-band from ;5 mL of sample using a Varian E-line
century series spectrometer ﬁtted with a MITEQ microwave ampliﬁer
(Varian, Hauppauge, NY) and a two-loop, one-gap resonator (Medical
Advances, Milwaukee, WI). Nonsaturated EPR spectra were obtained using
a microwave power of ;2 mW or less and a modulation amplitude of 1 G
peak-to-peak.
EPR spectroscopy was used to determine the interaction between proxyl-
PI(4,5)P2 and several SCAMP-E peptides listed in Table 1, as described
previously (Rauch et al., 2002). Brieﬂy, the peptide was added in steps from
a concentrated stock solution to 50–100 mL of a 20-mM lipid vesicle
suspension (0.25–0.5% proxyl-PI(4,5)P2) while the ﬁrst derivative peak-
to-peak amplitude of the central proxyl nitroxide resonance, A(0), was
recorded. The EPR spectrum of proxyl-PI(4,5)P2 in the presence of the
SCAMP-E peptide is a sum of EPR signals from free lipid and lipid bound to
the peptide. As discussed below, the fraction of bound proxyl-PI(4,5)P2 may
be determined from the value of A(0).
EPR power saturation measurements
Power saturation measurements on spin-labeled SCAMP-E peptides were
used to determine the depth of the nitroxide label from the level of the lipid
phosphate (Altenbach et al., 1994). Power saturation was performed as
described previously (Rauch et al., 2002) using gas permeable TPX capillary
tubes (Medical Advances, Milwaukee WI). The parameter P1/2 was
measured under three sets of conditions: in the presence of Air (20% O2),
N2, or N2 1 20 mM aqueous nickel (II) ethylenediaminediacetic acid
(NiEDDA), as described previously (Victor and Caﬁso, 2001). The values of
DPoxy
1=2 or DP
NiEDDA
1=2 were then determined from the difference in P1/2 values
in the presence and absence of either O2 or NiEDDA, respectively. For each
sample a depth parameter, F, was determined from the values of DP1/2
according to
F[ln
DP
oxy
1=2
DP
NiEDDA
1=2
" #
: (2)
The value of F is related to the local concentrations of O2 and NiEDDA,
which vary as a function of depth in the lipid bilayer. As a result,F provides
an estimate of the nitroxide depth in the lipid bilayer (Altenbach et al., 1994).
SCHEME 1
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A previously deﬁned calibration curve was used to estimate the position of
the nitroxide labels on SCAMP-E in either PC/PS- or PC/PS/PI(4,5)P2-
containing membranes (Frazier et al., 2002).
Analysis of EPR binding data
The 1:1 binding of SCAMP-E to proxyl-PI(4,5)P2 was analyzed in a manner
similar to that described previously for the equilibrium
M1 PIP24M  PIP2: (3)
The apparent association constant, Ka, for 1:1 binding is given by
Ka ¼ ½M  PIP2½M½PIP2 ; (4)
where [M-PI(4,5)P2] is the concentration of macromolecule: PI(4,5)P2
complex, [PI(4,5)P2] is the concentration of free PI(4,5)P2, and [M] is the
concentration of macromolecule in aqueous solution (Wang et al., 2001). In
addition, if [M]T and [PI(4,5)P2]T represent the total concentrations of
macromolecule and PI(4,5)P2, respectively, we may write
½MT ¼ ½M1 ½M  PIP2 (5)
½PIP2T ¼ ½PIP21 ½M  PIP2: (6)
The solution of Eqs. 4–6 yields a quadratic that can be used to predict the 1:1
binding as a function of the concentration of SCAMP-E, neomycin, or other
PI(4,5)P2 binding species. This expression can be used to predict the
amplitude of the central EPR resonance amplitude, A(0), as a function of
added macromolecule. The EPR spectrum is a simple sum of EPR spectra
from the free and bound proxyl-PI(4,5)P2 as a result the magnitude of A(0)
may be written as
Að0Þ ¼ ½PIP2½PIP2T
Af 1
½M  PIP2
½PIP2T
Ab; (7)
where Af and Ab represent the intrinsic amplitudes of free and
macromolecule-associated proxyl-PI(4,5)P2. Equation 7 was used in
combination with Eqs. 4–6 to determine the 1:1 binding behavior of
proxyl-PI(4,5)P2.
Bicelle and peptide samples for
NMR spectroscopy
Proton NMR chemical shift assignments for SCAMP-E (N-acetylated
version) were obtained using a solution of 3 mM SCAMP-E, 10% D2O, pH
4.2. The SCAMP-E peptide does not produce resolvable 1H resonances
when bound to lipid bilayers, and a bicelle system was chosen that contained
physiologically relevant levels of negatively charged lipid. The bicelle
samples containing SCAMP-E were formed by preparing a concentrated
solution of DCPC (dicaproylphosphatidylcholine) in H2O in a glove bag
ﬁlled with dry nitrogen. Appropriate amounts of dry dimyristoylphospha-
tidylcholine (DMPC), dimyristoylphosphatidylglycerol (DMPG), and
SCAMP-E were then added to the DCPC solution followed by an
appropriate amount of 1 M NaCl in D2O. The volume was adjusted with
H2O to 90% of the ﬁnal volume, the pH was adjusted to 5.5, and the sample
was diluted to the ﬁnal volume. The mixture was freeze-thawed ﬁve times
and the pH checked. The sample contained 4 mM SCAMP-E, 150 mM
NaCl, 0.15 w/v bicelles, 10% (v/v) D2O, pH 5.5. The lipid content of the
bicelles was 67 mol % DCPC, 20 mol % DMPG, 13 mol % DMPC.
Samples for spin-lattice relaxation experiments were degassed by using
the freeze-pump-thaw method and then equilibrated with 9 atm of O2 or N2.
NMR spectroscopy
NMR spectroscopy was performed using Varian UnityPlus and Inova 500
MHz spectrometers at 37C. The amide and aromatic regions of the one-
dimensional 1H spectra of bicelle-bound SCAMP-E peptide were selectively
excited using e-SNOB (selective excitation for biomedical applications)
pulses (Kupce et al., 1995). The PENCE (pulse with enhanced selectivity)
sequence containing an r-SNOB selective pulse (Kupce et al., 1995) was
used to selectively excite the 6.5- to 10-ppm spectral region in v2-selective
total correlation spectroscopy (TOCSY) (mixing times 30 ms, 60 ms, and
100 ms) and nuclear Overhauser effect spectroscopy (NOESY) (mixing
times 40 ms, 75 ms, 150 ms, and 250 ms) experiments (Seigneuret and Levy,
1995) for SCAMP-E in bicelles. Standard pulse sequences from Varian were
used to obtain the TOCSY (mixing times 50 ms, 100 ms, and 150 ms) and
rotating-frame NOESY (ROESY) (mixing times 150 ms and 200 ms) spectra
of SCAMP-E in solution. The inversion recovery method was used for spin-
lattice relaxation measurements. Spin-lattice relaxation rates due to the
presence of molecular oxygen (R1para) were obtained by measuring the
relaxation rate (R1) for a sample which was equilibrated with 9 atm of N2.
The sample was then degassed and equilibrated with 9 atm of O2 and the R1
experiment was repeated. The value of R1para was obtained by subtracting R1
for samples equilibrated with N2 from R1 for the same samples equilibrated
with O2.
Determining the position of bicelle-bound peptide
from oxygen paramagnetic enhancements
of 1H relaxation
As described previously, the values of R1para vary as a function of depth
within a lipid bicelle and reﬂect the increase in oxygen solubility within the
hydrocarbon (Ellena et al., 2002; Luchette et al., 2001; Prosser et al., 2000,
2001; Windrem and Plachy, 1980). A model for the position of SCAMP-E at
the interface was generated from the values of R1para for SCAMP-E bound to
bicelles in combination with lipid proton depths, lipid R1para values and
a model for the structure of SCAMP-E. Membrane-bound SCAMP-E ap-
pears to be at least partially helical (Hubbard et al., 2000), and an a-helical
model of SCAMP-E was constructed and the coordinates for each resolvable
SCAMP-E proton were obtained. The intrabilayer position of SCAMP-E
was then deﬁned by its depth and three Euler angles. The relationship
between the value of R1para and bilayer depth was deﬁned empirically as
R1para ¼ A tanh½Bðx  CÞ1D; (8)
where the values of A, B, C, and D are constants that deﬁne the bulk values
of R1para and the position of the curve. The position of SCAMP-E and the
parameters that deﬁne the hyperbolic tangent function were then ﬁt to the
values of R1para using lipid values of R1para as calibration points.
The hyperbolic tangent function (Eq. 8) was chosen because it describes
the distance behavior of the oxygen-based EPR determined depth parameter
given in Eq. 2 (Frazier et al., 2002). The EPR depth parameter F is de-
pendent on the local concentration of O2 (Altenbach et al., 1994), as is the
value of R1para (Ellena et al., 2002; Prosser et al., 2001). The effects of
nuclear motion have little effect upon R1para, because R1para is dominated by
the very large electron spin-lattice relaxation rate (Teng et al., 2001).
As indicated above, the values of R1para for the lipid protons were used as
calibration points. Depths for the lipid headgroup and glycerol protons were
estimated by constructing a bilayer containing the A and B forms of the
DMPC crystal structure (Pearson and Pascher, 1979) and measuring the
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average distance (for the two crystal forms) from the lipid protons to a plane
deﬁned by the lipid phosphorus atoms. The same approach was taken for the
acyl chain protons except that the effects of chain order on distance were
included (Salmon et al., 1987), using the acyl chain order parameters for
bicellar DMPC at 40C (Vold and Prosser, 1996).
RESULTS
PI(4,5)P2 enhances the binding of SCAMP-E
peptide to membranes
Membrane binding afﬁnities were measured for the SCAMP-
E peptide to membrane vesicles composed of PC, PC 1 1
mol % PI(4,5)P2, and PC 1 3 mol % PI(4,5)P2. Shown in
Fig. 1 are plots of the fraction of SCAMP-E bound to
membranes as a function of lipid concentration measured
using a 3H-labeled peptide. The solid lines represent the best
ﬁts through the data as deﬁned by Eq. 1 and yield the
reciprocal molar lipid binding constant of the peptide. From
these data, the afﬁnity of SCAMP-E to PC membranes is
found to be 1.3 3 102 M1, close to the value reported
previously using a spin-labeled E-peptide and EPR spec-
troscopy (Hubbard et al., 2000). When PC membranes
contain 1 mol % PI(4,5)P2 the afﬁnity of SCAMP-E
increases ;6-fold, and when the membranes contain 3%
PI(4,5)P2 the membrane afﬁnity is ;100-fold larger. The
binding increase seen in the presence of PI(4,5)P2 is likely to
result from the Coulombic interaction of positively charged
residues on SCAMP-E with the negatively charged mem-
brane surface. The zeta potential of bilayers composed of PC
and 3 mol % PI(4,5)P2 is;20 mV (Wang et al., 2001), and
from the Boltzmann relation a 20-fold enhancement in
binding would be expected for a point charge of valence 14
from this potential. Thus, the binding increase observed here
represents a slight increase over what would be expected
from a purely nonspeciﬁc Coulombic interaction with a
uniform membrane charge distribution. This increase may
arise from a localized electrostatic effect or discreetness-
of-charge effects as discussed previously for the MARCKS-
ED (Wang et al., 2002).
The SCAMP-E peptide binds to proxyl-PI(4,5)P2
Shown in Fig. 2 A are EPR spectra of the spin-labeled
PI(4,5)P2 analog, proxyl-PI(4,5)P2, incorporated into PC
bilayers in the presence and absence of SCAMP-E peptide.
The lineshape recorded in the absence of peptide (gray line,
Fig. 2 A) is identical to that reported previously for proxyl-
PI(4,5)P2 in PC (Rauch et al., 2002) and indicates that the
FIGURE 1 Membrane binding of 3H-NEM-SCAMP E-peptide (14) to
PC vesicles (s), 1% PI(4,5)P2 in PC (:), and 3% PI(4,5)P2 in PC (d) as
a function of the concentration of accessible lipid. The reciprocal molar
binding constants for PC, 1% PI(4,5)P2, 3% PI(4,5)P2 are 130, 8.9 3 10
2,
and 1.4 3 104 M1, respectively. The radiolabeled peptide is at a
concentration of 40 nM. The membrane vesicles are extruded into a buffer of
100 mM KCl, 1 mM MOPS, pH 7.0.
FIGURE 2 (A) EPR spectra of proxyl-PI(4,5)P2 in the absence (gray
trace) and presence (black trace) of ;1 mM SCAMP-E peptide. The
membrane vesicles contain PC with ;0.25 mol % proxyl-PI(4,5)P2. (B)
Titration of the central EPR resonance of proxyl-PI(4,5)P2 as a function of
the concentration of added SCAMP-E peptide. The total proxyl-PI(4,5)P2
concentration is 50 mM in PC vesicles at a lipid concentration of 20 mM.
The solid line represents a nonlinear least squares ﬁt through the data
using Eqs. 3–6, assuming a 1:1 stoichiometry, and yields a value for Ka of
3 3 104 M1.
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probe is incorporated into the vesicle membrane. This EPR
spectrum results from a nitroxide having an effective
correlation time of ;1.5–2 ns. At least one component of
the motion of this probe is likely the rapid nanosecond
rotational diffusion about the long axis of the lipid. When
excess SCAMP-E peptide (black line, Fig. 2 A) is added to
the proxyl-PI(4,5)P2/PC sample, the EPR spectrum broadens
and decreases in amplitude, indicating that there is an
interaction between the peptide and the lipid probe. This
broadening in the EPR spectrum indicates that the
correlation time of the nitroxide on proxyl-PI(4,5)P2 has
increased and is ;2–3 ns in the presence of SCAMP-E.
Similar lineshape changes for proxyl-PI(4,5)P2 in PC were
seen upon the addition of either neomycin or the PH domain
from PLC-d1, two molecules that are known to bind
PI(4,5)P2 (Rauch et al., 2002). The changes in lineshape
seen in Fig. 2 A are likely to result from a decrease in the
rotational diffusion rate of proxyl-PI(4,5)P2 that would take
place upon association of the SCAMP-E peptide with the
phosphoinositol headgroup. Fig. 2 B is a plot the central EPR
line amplitude from proxyl-PI(4,5)P2 as a function of the
addition of SCAMP-E peptide. The solid line in Fig. 2 B
represents the best ﬁt to the EPR amplitudes using the 1:1
binding model described by Eqs. 3–7, and this ﬁt yields an
association binding constant (Eq. 4) for the interaction of
SCAMP-E with proxyl-PI(4,5)P2 of 10
4 M1.
In addition to the native SCAMP-E peptide (CWYRPIY-
KAFR), we tested two analogs of SCAMP-E (See Table 1)
to determine whether they also interacted with proxyl-
PI(4,5)P2. In these two peptides, the amino acid composition
was identical to that of the native peptide except that either
residues 6 and 11 or residues 4 and 5 and 9, 10, and 11 had
been switched. These two scrambled peptides produced
nearly identical results to those shown in Fig. 2 for the native
SCAMP-E peptide, indicating that the speciﬁc order of the
positively charged and aromatic residues was not critical to
the interaction with the labeled PI(4,5)P2.
The cytoplasmic surface of a plasma membrane typically
contains a substantial fraction of monovalent negatively
charged lipid such as PS. To determine whether negatively
charged lipids might interfere with the interaction between
proxyl-PI(4,5)P2 and the native SCAMP-E peptide, the
experiment shown in Fig. 2 was repeated in membranes
composed of PC/PS (70:30). In the presence of negatively
charged lipid, virtually identical results to those shown in
Fig. 2 B were obtained, indicating that the presence of mono-
valent negatively charged lipids do not signiﬁcantly alter the
interaction between SCAMP-E and proxyl-PI(4,5)P2.
SCAMP-E peptide inhibits PLC-b and PLC-d1
activity on monolayers
The data shown in Fig. 1 indicate that the SCAMP-E peptide
prefers to bind to membranes containing PI(4,5)P2, and the
data in Fig. 2 indicate that SCAMP-E directly interacts with
the proxyl-PI(4,5)P2 headgroup in the membrane. To further
test for a SCAMP-E peptide-PI(4,5)P2 interaction, the effect
of the SCAMP-E peptide on the activity of both PLC-d1 and
PLC-b on monolayer surfaces was measured. If SCAMP-E
has a greater afﬁnity for PI(4,5)P2 than the active site of these
enzymes, the peptide should decrease the rate at which these
PLCs are able to hydrolyze PI(4,5)P2 on a monolayer sur-
face. Shown in Fig. 3 are plots of the fraction of radio-
labeled PI(4,5)P2 hydrolyzed by either PLC-d1 or PLC-b in
the absence or presence of SCAMP-E peptide. For either PLC
isoform, addition of 1 mM SCAMP-E to the monolayer sub-
phase produces a .90% reduction in the rate of enzy-
matic activity. This inhibition by SCAMP-E suggests
that the peptide has the capacity to bind and sequester
PI(4,5)P2, making the lipid inaccessible to the active site on
either PLC isoform.
FIGURE 3 Effect of the addition of the SCAMP-E peptide on the
hydrolysis of PI(4,5)P2 on monolayers by either (A) PLC-d1 at peptide
concentrations of zero (d), 1 mM (:), and 10 mM (s); or (B) PLC-b at
peptide concentrations of zero (d), 100 nM (:), and 1 mM (s).
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Site-directed spin labeling indicates that
SCAMP-E peptide binds below the level of the
lipid phosphates and does not change position
or structure in the presence of PI(4,5)P2
Site-directed spin labeling (SDSL) was used to determine the
position of SCAMP-E in the membrane interface and
determine whether the presence of PI(4,5)P2 in the membrane
altered the position or structure of SCAMP-E. Previous work
indicated that the SCAMP-E peptide has a random structure in
solution, but assumes an ;30% helical structure upon
membrane association (Hubbard et al., 2000). The native
peptide and two mutant peptides (see Table 1) having single
cysteine residues (I6C and A9C) were modiﬁed with the
MTSL. Shown in Fig. 4 are the EPR spectra of the R1 label at
positions 1, 6, and 9 for the SCAMP-E peptide fully bound to
vesicles composed of PC, PC/PS, or PC/PS/PI(4,5)P2. In each
case the spectra have correlation times of 2–3 ns and are
similar to other EPR spectra for R1 side chains on peptides
that are positioned within the membrane interface. The EPR
spectrum at position 1 arises from a label having slightlymore
motion than those at positions 6 and 9 (there is a ;20%
difference in correlation times). For each label, the spectra in
PC, PC/PS (75:25), or PC/PS/PI(4,5)P2 (73:22:5) are re-
markably similar. The similarity of these spectra and the
relatively mobile lineshapes indicate that there are no
dramatic changes in structure of the peptide or speciﬁc
tertiary contactsmade between the labeled peptide side chains
and PI(4,5)P2.
To determine the membrane position of the spin-labeled
side chains relative to the lipid phosphates, the EPR spectra
of spin-labeled SCAMP-E peptides bound to PC/PS or PC/
PS/PI(4,5)P2 vesicles were power saturated (see Methods).
Shown in Table 2 are the distances obtained for the R1 side
chain relative to the lipid phosphate. Each label sits at a
position 7–9 A˚ below the level of the lipid phosphates on
the hydrocarbon side of a plane deﬁned by the carbonyl car-
bons. The depths of the R1 labels are unchanged within ex-
perimental error in the presence of PI(4,5)P2. As discussed
previously, these depths should approximate the position
assumed by nonpolar side chains on this peptide (Qin and
Caﬁso, 1996). If the most likely conﬁguration for the
nitroxide side chain R1 is assumed (Altenbach et al., 2001;
Langen et al., 2000), these positions indicate that the
backbone of the SCAMP-E peptide lies at or below the
level of the lipid phosphates.
Interfacial location of SCAMP-E determined by
high-resolution NMR in bicelles
Shown in Fig. 5 are NMR spectra of the SCAMP-E peptide
in aqueous solution and bound to DCPC/DMPG/DMPC
(67:20:13) bicelles. As expected, many 1H resonances are
resolved for SCAMP-E bound to bicelles, but they are
signiﬁcantly broader than resonances acquired from the
peptide in aqueous solution. Proton chemical shift assign-
ments for the SCAMP-E peptide were determined using
standard techniques from 1H TOCSY and ROESY spectra of
SCAMP-E in solution, and 1H TOCSY and NOESY spectra
of SCAMP-E in bicelles (Wuthrich, 1986). The chemical
shift positions in solution and bicelle-bound peptide are
similar (see Fig. 5) and the assignment of the SCAMP-E 1H
chemical shifts in solution facilitated the assignment of the
bicelle-bound SCAMP-E 1H chemical shifts (See Supple-
mentary Material for chemical shift assignments).
Proton spin-lattice relaxation rates were measured for
the peptide-bicelle system in the presence and absence of
FIGURE 4 EPR spectra of spin-labeled derivatives of the SCAMP-E
peptide when fully bound to PC, PC/PS (75:25), or PC/PS/PI(4,5)P2
(73:22:5) membrane vesicles. The spin-labeled side chain when placed at
position 1 has an apparent rotational correlation time of ;2 ns. At positions
6 and 9 the apparent rotational correlation times are slightly longer and have
values of;2.4 ns. The lineshapes are virtually unchanged in the presence of
PI(4,5)P2, indicating that the spin-labeled side chain does not experience
a change in tertiary environment in the presence of PI(4,5)P2. This result is
consistent with the hypothesis that the interaction between the SCAMP-E
peptide and PI(4,5)P2 is mediated largely by electrostatic interactions.
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oxygen. Shown in Fig. 6 are the paramagnetic enhancements
of proton spin-lattice relaxation rates due to oxygen, R1para,
for lipid and peptide protons (see Supplementary Material for
a list of these rates). As seen in Fig. 6, the value of R1para for
the bilayer lipid protons increases as one proceeds from the
choline methyls of the headgroup to the methyls of the fatty
acid chains. This behavior has been observed previously
(Ellena et al., 2002, 2003; Prosser et al., 2000, 2001) and
is a result of the increased solubility of oxygen in the
membrane hydrocarbon phase (Windrem and Plachy, 1980).
The position of the SCAMP-E peptide at the lipid interface
was determined by varying the peptide orientation and depth
to obtain a best ﬁt of the measured values of R1para for the
peptide with the depth dependence of R1para (see Methods).
Shown in Fig. 7 are the depths for peptide protons obtained,
the lipid depth data, which were used as calibration points,
and a line deﬁning the best ﬁt of Eq. 8 to the R1para data. In
this ﬁt, all SCAMP-E intrabilayer depths differ from the best-
ﬁt line by ,1.5 A˚. A few ﬂexible side-chain dihedral angles
were manually adjusted to obtain this ﬁt, along with small
changes to two backbone dihedral angles (R4 f and u were
changed from 65 to 85 and from 40 to 20,
respectively).
Shown in Fig. 8 is the location of SCAMP-E at the lipid
interface that was obtained from the ﬁt to the 1H relaxation
data shown in Fig. 7. The SCAMP-E helical axis (backbone
shown in yellow) is nearly coincident with the carbonyl
carbon plane, which is in the bilayer interface region
(Hristova and White, 1998). The peptide is amphipathic
FIGURE 5 1H NMR spectra (500 MHz) showing the aromatic and
guanidino 1H resonances of SCAMP-E in (A) solution and (B) DCPC/
DMPG/DMPC (67:20:13) bicelles. The resonances are broader in bicelles
but have similar chemical shifts. (See Supplementary Material for chemical
shift assignments).
FIGURE 6 Oxygen-induced spin-lattice relaxation rates (R1para) in units
of s1 for several bilayer lipid (n) and SCAMP-E peptide (d) 1H resonances.
The lipid bilayer resonances are arranged in order of increasing distance
(left to right) from the membrane surface.
FIGURE 7 Relationship between bilayer depth and O2-induced spin-
lattice relaxation rate (1/T1para). Paramagnetic enhancements for bilayer lipid
protons (d) and SCAMP-E (s) bound to bicelles (Fig. 6). The solid line is
the best ﬁt of the data to a hyperbolic tangent function: 1/T1para ¼ A tanh[B(x
 C)] 1 D, where x is the distance between the relaxing nucleus and the
lipid phosphorus atom plane, and the ﬁtted parameters are A¼ 3.1, B¼ 0.16,
C ¼ 3.2, D ¼ 3.5. The ﬁt also generates an orientation for the SCAMP-E
peptide at the membrane interface (see Fig. 8).
TABLE 2 Membrane depths for spin labels on SCAMP-E
peptide
PC/PS (3:1) PC/PS/PI(4,5)P2 (73:22:5)
Peptide F d (A˚) F d (A˚)
C1R1 0.64 7.3 0.82 7.8
I6R1 0.76 7.6 1.3 9.1
A9R1 1.2 8.8 1.2 8.8
The membrane depth, d, corresponds to the position of the nitroxide side
chain from the level of the lipid phosphate where positive values indicate
a position within the bilayer. The error in the depth due to the error in F is
;61 A˚.
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and most of the aromatic side chains (shown in green) are
located in the lipid hydrocarbon. Thus, the picture obtained
from the NMR data in bicelles is consistent with the location
of the R1 side chain obtained by EPR depth measurements.
In addition, this model places the charged side chains (shown
in red) at or deeper than the level of the lipid phosphates. In
particular, the R4 and R11 1Hh (guanidino hydrogens) reside
2 A˚ deeper than the carbonyl carbons of the lipid.
Two additional sets of NMR data are consistent with the
position shown in Fig. 8. First, three broad peaks appear in
the backbone HN region of the 1H spectrum of SCAMP-E in
bicelles. Because of spectral overlap, more than one back-
bone HN contributes to each of these peaks, and we did
not use these data to generate the structure shown in Fig. 8.
However, these three peaks have similar values of R1para,
which average to 3.46 0.4 s1. Comparing this rate to those
for the lipids (Fig. 6) indicates that that these backbone HN
protons assume a position near the glycerol backbone.
Second, two-dimensional 1H-1H NOESY spectra indicate
that there are crosspeaks between side-chain resonances of
SCAMP-E (aromatic and R-guanidino) and acyl resonances
of the bicelle lipids at relatively short (75-ms) mixing times
(see Supplementary Material). Because these NOE data are
much less quantitative than the R1para with respect to peptide
position, they were not used to produce the model in Fig. 8.
DISCUSSION
The results described here provide evidence that a basic
aromatic peptide derived from SCAMP2 has the capacity to
sequester PI(4,5)P2 within the bilayer. Three observations
suggest that the SCAMP-E peptide interacts with PI(4,5)P2.
First, the results of binding measurements (Fig. 1) indicate
that this peptide has an enhanced afﬁnity toward membranes
composed of PI(4,5)P2. Second, membrane binding of the
peptide slows the rotational correlation time of a spin-labeled
analog of PI(4,5)P2, proxyl-PI(4,5)P2. Finally, this peptide
inhibits the enzymatic activity of both PLC-d1 and PLC-b on
lipid monolayers by over 90% when present in the subphase
at concentrations of 1 mM.
When compared to the MARCKS-ED, the SCAMP-E
peptide binds much more weakly to PI(4,5)P2 containing
membranes. The SCAMP-E peptide binding constant to PC
membranes increases 100-fold when 3 mol % PI(4,5)P2 is
present. For the MARCKS-ED, a 10,000-fold increase in
binding constant in the presence of 1 mol % PI(4,5)P2 is
observed (Wang et al., 2001). Nonetheless, the SCAMP-E
afﬁnity is signiﬁcant and ;50% of the peptide will be
membrane-bound in the presence of 106 M PI(4,5)P2 in PC
membranes. This is similar to the binding constant measured
for the interaction of neomycin (105 M) (Gabev et al., 1989)
or the PH domain of PLC-d1 (106 M) with PI(4,5)P2
(Garcia et al., 1995). It should be noted that these afﬁnities
are not entirely comparable, because the SCAMP-E peptide
binds to pure PC membranes whereas neomycin and the PH
domain do not.
A second determination of the strength of the interaction
between PI(4,5)P2 and the SCAMP-E peptide was made by
measuring the amplitude of the EPR spectrum of proxyl-
PI(4,5)P2 as a function of peptide concentration. This
titration (Fig. 2 B) was carried out under high lipid
concentrations so that all the added peptide was mem-
brane-bound. Under these conditions, the interaction be-
tween SCAMP-E and proxyl-PI(4,5)P2 was found to have
a binding constant of 104 M1 (see Eq. 4). This binding
constant is 100 times weaker than the binding measured by
membrane partitioning, a difference that reﬂects the different
conditions used in the two types of binding experiments. The
EPR measurement using proxyl-PI(4,5)P2 provides a mea-
sure of the free energy of interaction between peptide and
lipid once the peptide is membrane-bound, whereas the
binding data in Fig. 1 provide a measure of free energy of
transfer from the aqueous solution to the membrane
interface.
A third measure of the interaction between SCAMP-E and
PI(4,5)P2 was obtained by examining the enzymatic activity
of PLC on monolayer surfaces. The data presented here
indicate that SCAMP-E is quite potent at inhibiting the
enzymatic hydrolysis of PI(4,5)P2 by PLC, a ﬁnding that is
consistent with the EPR result indicating that SCAMP-E
binds PI(4,5)P2 within the plane of the bilayer. The
MARCKS-ED is more inhibitory than the SCAMP-E
peptide, producing a 90% inhibition of PLC activity at
a concentration of 100 nM (a 10-fold lower peptide
concentration than that required for SCAMP-E). However,
heptalysine (Lys7) produces little inhibition even when
present at a 100-times higher concentration than that required
FIGURE 8 Location of SCAMP-E when bound to a bilayer. The data in
Fig. 6 were used to position SCAMP-E in a PC bilayer leaﬂet (bilayer
coordinates from Scott E. Feller, http://persweb.wabash.edu/facstaff/fellers)
(Armen et al., 1998). The best-ﬁt planes of the bilayer phosphorus and
carbonyl atoms are shown and are perpendicular to the page. The SCAMP-E
peptide backbone is shown in yellow, positively charged side chains are red,
and nonpolar side chains are green. The two arginine and one lysine residue
are labeled. Although the placement of the aromatic and arginine side chains
relative to the membrane interface is deﬁned by values of R1para, there is
considerable uncertainty regarding the conformation of the peptide. It was
not possible to determine the structure from 1H NMR data of the bicelle-
bound peptide, and this peptide may in fact exist in a mixture of con-
formational forms.
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for inhibition by SCAMP-E (Wang et al., 2002). Although
some of the differences in the inhibition produced by these
peptides may be due to differences in their membrane
binding, SCAMP-E appears to be particularly effective at
inhibiting PLC when peptides of roughly similar binding
energies are compared (Wang et al., 2002).
It should be noted that the simplest interpretation of these
enzymatic measurements is that SCAMP-E inhibits PLC
activity by binding and sequestering its substrate, PI(4,5)P2.
However, other interactions may play a role and cannot be
ruled out. Because the SCAMP-E peptide is deeply buried
within the interface when membrane-bound, it might alter
the lateral pressure proﬁle within membranes. PLC is known
to be modulated by lateral pressure (Boguslavsky et al.,
1994; Rebecchi et al., 1992) and it is conceivable that some
of the effect of the SCAMP-E peptide observed here on PLC
may be mediated by changes in lateral pressure.
A number of observations indicate that the interaction
between SCAMP-E and PI(4,5)P2 is driven by nonspeciﬁc
electrostatic interactions. There is good evidence that the
MARCKS-ED interacts with PI(4,5)P2 through a nonspeciﬁc
electrostatic mechanism. The MARCKS-ED has a valence of
113 and PI(4,5)P2 has an average valence of 3 to 4.
Multiple PI(4,5)P2 (probably 3–4) are bound by the
MARCKS-ED and this stoichiometry is consistent with that
expected for an electrostatic interaction (Gambhir et al.,
2004; Rauch et al., 2002; Wang et al., 2002, 2004). In the
case of the SCAMP-E peptide the binding data are well ﬁt by
Eqs. 4–7, which assume a 1:1 stoichiometry. A 1:1 stoi-
chiometry would be expected if the interactions between the
SCAMP-E peptide and PI(4,5)P2 are also driven by non-
speciﬁc electrostatic interactions, since there are approxi-
mately equal charges on SCAMP-E and PI(4,5)P2.
Site-directed spin labeling also suggests that nonspeciﬁc
interactions drive the interaction between the SCAMP-E
peptide and PI(4,5)P2. As shown in Fig. 4, the EPR
lineshapes of spin-labeled SCAMP-E are remarkably
similar, irrespective of the lipid to which the peptide is
bound. In addition to lineshapes, the depths of the R1 labels
when bound to membranes are unchanged by the presence of
PI(4,5)P2 (Table 2). The EPR spectrum of the spin-labeled
side chain R1 is highly sensitive to changes in tertiary
contact or backbone dynamics (Columbus et al., 2001;
Hubbell et al., 1998), and the absence of a change in
lineshape or membrane depth indicates that SCAMP-E has
a similar conﬁguration and is interacting similarly with
membranes in either the absence or presence of PI(4,5)P2. A
similar observation was made using SDSL for spin-labeled
peptides derived from the MARCKS-ED (Rauch et al.,
2002).
Two variants of the SCAMP-E peptide having an identical
amino acid composition to that of native SCAMP-E, but with
altered sequences, appear to sequester proxyl-PI(4,5)P2 with
approximately the same afﬁnity as the native peptide. This
observation suggests that amino acid composition rather than
sequence is important for the interaction of SCAMP-E with
PI(4,5)P2. Taken together, these observations indicate that
the interaction between the SCAMP-E peptide and PI(4,5)P2
does not involve speciﬁc molecular contacts or hydrogen
bonding, and that the interaction is most easily explained by a
mechanism that is electrostatic in origin.
If electrostatic interactions between peptides like
SCAMP-E and PI(4,5)P2 are relevant on the cytoplasmic
surface of the plasma membrane, they must occur in the
presence of signiﬁcant levels of negatively charged lipid. As
indicated above, the presence of 30 mol % phosphatidylser-
ine within a PC bilayer does not inhibit the interaction
between SCAMP-E and the spin-labeled proxyl-PI(4,5)P2.
This is consistent with the ﬁnding that the MARCKS-ED
sequesters PI(4,5)P2 in the presence of 15–35 mol % PS
(Gambhir et al., 2004), and with a computational study on
the electrostatic interactions between basic peptides and
PI(4,5)P2. In the presence of 15–35 mol % negatively
charged lipid, signiﬁcant positive potentials are predicted
close to the MARCKS-ED when it is localized on the
membrane interface (Wang et al., 2004). Negatively charged
monovalent lipid produces a negative electrostatic surface
potential at regions far from the peptide. PI(4,5)P2 will
preferentially interact with the peptide because the Boltz-
mann relation predicts a much stronger interaction with the
peptide for a lipid with a valence of 4 (PI(4,5)P2) than a
lipid with a valence of 1 (PS). Highly charged peptides,
such as those from MARCKS, are predicted to have many
energetically equivalent favorable sites for association with
PI(4,5)P2 (Wang et al., 2004). The SCAMP-E peptide likely
produces such a local electrostatic free energy minimum for
PI(4,5)P2.
The position of the SCAMP-E peptide at the membrane
surface is similar to that assumed by the MARCKS-ED
peptide (Ellena et al., 2003; Qin and Caﬁso, 1996; Zhang
et al., 2003). The EPR data obtained here place the R1 side
chains (positions 1, 6, and 9) on the spin-labeled SCAMP-E
peptides several A˚ below the level of the membrane
phosphorus atoms. Likewise the NMR data show that the
Phe and Tyr side chains of the SCAMP-E peptide lie in the
hydrocarbon region of the bicelles, with the peptide back-
bone at or very close to the level of the carbonyl carbons.
The orientation and depth obtained for SCAMP-E also
provides information on the positions of the arginine re-
sidues on the peptide. Obtaining direct information on the
position of the charged residues in the MARCKS-ED has
been more problematic due to its highly redundant sequence.
For SCAMP-E, the data acquired for R4 and R11 guanidino
hydrogens indicate that the positive charges of these arginine
side chains lie ;2 A˚ deeper than the carbonyl carbons.
The interfacial position of the arginine side chains may
seem surprising because it should entail a signiﬁcant Born
energy penalty. However, this electrostatic penalty is dif-
ﬁcult to estimate because the effective dielectric constant
in the interfacial region is not precisely known, and because
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the interface is highly anisotropic. The charge on arginine is
partially delocalized, which will increase its ionic radius and
lower its Born energy. If a radius of 2A˚ and a dielectric
constant of 20 are assumed, the Born energy penalty would
be 6 kcal/mole to transfer two arginines into the interface.
However, this may be an overestimate since the transfer free
energy for moving two entire arginine residues from water to
octanol (dielectric constant 10) is estimated to be 13.6 kcal/
mole (White and Wimley, 1998). Two types of favorable
interactions may act to balance out this energy penalty. First,
water-interfacial hydrophobicity scales predict that the four
aromatic side chains on the peptide will contribute a total of
;5 kcal/mole to the partition free energy of the peptide
(White and Wimley, 1998). Second, the charged side chains
interact favorably with the negatively charged interface and
this interaction will lower the binding free energy. For a
lysine residue positioned at an interface containing nega-
tively charged lipid, the Coulombic interaction will lower
the energy of the bound peptide by 1.4 kcal/mole (Kim et al.,
1991). As a result, the position of the arginine residues in
SCAMP-E shown in Fig. 8 is not inconsistent with the total
binding energy expected for this peptide.
The electrostatic ﬁeld on the membrane interface that
results from these charged side chains will also be enhanced
as a consequence of placing these charges within a low
dielectric region of the interface (McLaughlin, 1977). A
recent computational study indicates that PI(4,5)P2 seques-
tration is enhanced as charged peptides are moved from the
aqueous phase closer to the membrane interface (Wang et al.,
2004). In this case, the position of the SCAMP-E peptide
within the interface might be particularly important for an
electrostatic sequestration mechanism, and may explain the
potent ability of SCAMP-E to bind PI(4,5)P2.
The aromatic residues of the SCAMP-E peptide are likely
to drive this peptide into the membrane interface. In contrast
to the position found for SCAMP-E and the MARCKS-ED,
positively charged peptides lacking hydrophobic residues,
such as pentalysine, hexalysine, or the N-terminal fragment
of src (myr-src(2–16)), reside several A˚ on the aqueous side
of the lipid interface within the aqueous double layer (Victor
and Caﬁso, 1998, 2001). Indeed, replacing the ﬁve
phenylalanine residues in the MARCKS-ED peptide with
alanines shifts the equilibrium binding position of the
peptide more than 10 A˚ so that it resides in the aqueous
phase (Victor et al., 1999). These highly charged hydrophilic
peptides are believed to bind to membranes due to a long-
range Coulombic attraction, but fail to penetrate the bilayer
interface due to a desolvation repulsion that is experienced
near the membrane interface (Ben-Tal et al., 1996; Murray
et al., 1998). The addition of hydrophobic residues to the
sequence is thought to facilitate membrane penetration by
allowing the peptide to overcome the desolvation repulsion.
At this time, neither the role of the native SCAMP protein
nor the function of the highly conserved E segment is
understood. Evidence has been obtained implicating
SCAMPs in the membrane fusion that takes place during
exocytosis (Fernandez-Chacon et al., 1999; Guo et al., 2002;
Liu et al., 2002). Ablation of SCAMP1 impairs opening of
the fusion pore and the E segment of SCAMP2 inhibits
exocytosis when employed as a soluble peptide in per-
meabilized cells and when mutated within the full-length
protein and expressed in intact cells. As part of a short
amphipathic cytoplasmic linker connecting the second and
third transmembrane helices, the E segment is likely to bind
within the bilayer interface in the intact protein (Hubbard
et al., 2000). SCAMPs are present in high copy number
within the cell and also have a propensity to aggregate (Wu
and Castle, 1997; A. Castle, unpublished). As a consequence,
multiple copies of the E segment may be clustered and
positioned at the membrane interface. Collectively, these seg-
ments might act directly on the membrane interface to alter
the lateral distribution of polyphosphoinositides or modulate
the interfacial properties of the bilayer.
In summary, a positively charged but highly aromatic
peptide derived from a secretory carrier membrane protein
binds to PI(4,5)P2 containing membranes and interacts with
PI(4,5)P2 within the plane of the membrane. When bound to
lipid bilayers or bicelles, EPR and NMR methods indicate
that this peptide is positioned within the interface, so that the
peptide backbone is near the level of the lipid carbonyl
carbons. The charged residues on this peptide are placed at or
below a plane deﬁned by the lipid phosphates. The deep
interfacial position of these charged residues is likely to
facilitate interactions with PI(4,5)P2 through a nonspeciﬁc
electrostatic mechanism.
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